Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DynamX Medical

DynamX Medical
PRIVATE STATUS
2ndary - Private LATEST DEAL TYPE
8 INVESTORS
Description

Developer of biopsy triaging system designed to identify healthy and benign tissue specimens with high accuracy. The company's system helps to do healthy biopsies which could be quickly identified, before undergoing any processing and eliminated from the histopathology pathway, enabling physicians to treat their patients in an enhanced way.

Formerly Known As
BeamLine Diagnostics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Primary Office
  • Rutherford Appleton Laboratories
  • Building R103 Office R-103, Harwell Campus
  • Didcot OX11 0QX
  • England, United Kingdom
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore DynamX Medical’s full profile, request a free trial.

DynamX Medical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private 00.000 Completed Generating Revenue
6. Accelerator/Incubator 12-Jun-2018 00000 00.000 Completed Generating Revenue
5. Early Stage VC 07-Jun-2017 00000 00.000 00.000 Completed Generating Revenue
4. Early Stage VC 05-Apr-2016 00000 00000 00000 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
2. Grant 23-Jun-2015 $10K Completed Generating Revenue
1. Accelerator/Incubator 01-Mar-2015 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

DynamX Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 21,946 $0.001291 $8.82 $8.82 1x $8.82 12.46%
To view this company’s complete Cap Table, request access »

DynamX Medical Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
MedTech Innovator Accelerator/Incubator Minority 000 0000 000000 0
Angel Academe Accelerator/Incubator Minority 000 0000 000000 0
Angels in Med City Angel Group Minority 000 0000 000000 0
London Co-Investment Fund Venture Capital Minority 000 0000 000000 0
Founder.org Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

DynamX Medical Executive Team (4)

Name Title Board
Seat
Contact
Info
Liberty Foreman Ph.D Board Member, Co-Founder & Chief Executive Officer
Lance Farr Chief Technology Officer
Katherine Willetts Ph.D Board Member, Co-Founder & Chief Operating Officer

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

DynamX Medical Board Members (7)

Name Representing Role Since Contact
Info
Ian Smith Self Chairman 000 0000
Katherine Willetts Ph.D DynamX Medical Board Member, Co-Founder & Chief Operating Officer 000 0000
Liberty Foreman Ph.D DynamX Medical Board Member, Co-Founder & Chief Executive Officer 000 0000
Savvas Neophytou Ph.D Deepbridge Capital Board Member 000 0000
Tim Mustill DynamX Medical Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 7 board members. Get the full list »